AdvaMed® Commends Full House Passage of MDUFA V Agreement
The Advanced Medical Technology Association® (AdvaMed®) welcomes House passage of the MDUFA V agreement.
In New Report, AdvaMed® Seeks Ways to Increase Diversity in Clinical Research and Addressing Health Equities
The Advanced Medical Technology Association® (AdvaMed®) released a report titled “Approaches to Increasing Diversity in Clinical Research and Addressing Health Inequities”, a new document intended to outline considerations and approaches…
AdvaMed®, Member Company Executives Meet with Semiconductor Industry, Department of Commerce Officials on Chips to Ensure Patient Care Comes First
Scott Whitaker, President and CEO of the Advanced Medical Technology Association® (AdvaMed®), the largest global trade organization representing the medical technology sector, joined a meeting with Deputy Secretary of Commerce…
AdvaMed® Joins Biden Administration Working Group to Address Medtech Supply Chain Concerns That Could Soon Affect Patient Care
The Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade organization representing medical technology manufacturers, announced its new role in the Biden Administration’s Joint Supply Chain Resilience Working Group.
AdvaMed® Commends Unanimous House Committee Vote on MDUFA V Agreement
Scott Whitaker, president and CEO of AdvaMed®, the world’s largest trade association representing medical technology companies, released the following statement on progress this week in both houses of Congress.
New for Upcoming The MedTech Conference: AdvaMed® Announces Investor Forum, Including Session with Chief Executives for Corporate Purpose
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.
AdvaMed® Welcomes FDA User Fee Legislative Package
Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association® (AdvaMed®) released this statement from President and CEO Scott Whitaker.
AdvaMed®, Medtech Leaders, Commerce Secretary Raimondo Discuss Impact of Semiconductor Chip Shortage on Patient Care
Scott Whitaker, President and CEO of AdvaMed®, led a meeting of medtech CEOs and leaders with Secretary of Commerce Gina Raimondo to discuss semiconductor chip supply chain issues impacting the…
AdvaMed® Submits Recommendations to Federal Government to Strengthen Domestic Semiconductor Industry
The Advanced Medical Technology Association® (AdvaMed®) recently responded to the Department of Commerce’s request for information on ways to support a strong domestic semiconductor industry.
AdvaMed® Welcomes Opportunity to Testify on Historic Medical Device User Fee Agreement
AdvaMed® welcomes the opportunity to testify before a key congressional committee on the fifth reauthorization of the Medical Device User Fee Amendments (MDUFA).